# A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781

> **NCT03131141** · PHASE1 · COMPLETED · sponsor: **Nabriva Therapeutics AG** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BC-3781

## Key facts

- **NCT ID:** NCT03131141
- **Lead sponsor:** Nabriva Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-08
- **Primary completion:** 2017-10-09
- **Final completion:** 2018-03-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03131141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03131141, "A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03131141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*